- Home
- DOCS vs PEN Comparison
DOCS vs PEN Comparison
Compare DOCS & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCS
- PEN
- Stock Information
- Founded
- DOCS 2010
- PEN 2004
- Country
- DOCS United States
- PEN United States
- Employees
- DOCS N/A
- PEN N/A
- Industry
- DOCS Retail: Computer Software & Peripheral Equipment
- PEN Medical/Dental Instruments
- Sector
- DOCS Technology
- PEN Health Care
- Exchange
- DOCS Nasdaq
- PEN Nasdaq
- Market Cap
- DOCS 12.3B
- PEN 9.7B
- IPO Year
- DOCS 2021
- PEN 2015
- Fundamental
- Price
- DOCS $49.61
- PEN $281.41
- Analyst Decision
- DOCS Buy
- PEN Strong Buy
- Analyst Count
- DOCS 20
- PEN 16
- Target Price
- DOCS $68.55
- PEN $307.19
- AVG Volume (30 Days)
- DOCS 1.8M
- PEN 493.8K
- Earning Date
- DOCS 11-06-2025
- PEN 11-05-2025
- Dividend Yield
- DOCS N/A
- PEN N/A
- EPS Growth
- DOCS 42.88
- PEN 367.34
- EPS
- DOCS 1.25
- PEN 4.14
- Revenue
- DOCS $621,329,000.00
- PEN $1,333,798,000.00
- Revenue This Year
- DOCS $13.54
- PEN $15.52
- Revenue Next Year
- DOCS $11.26
- PEN $14.20
- P/E Ratio
- DOCS $39.74
- PEN $67.68
- Revenue Growth
- DOCS 20.21
- PEN 14.61
- 52 Week Low
- DOCS $47.66
- PEN $221.26
- 52 Week High
- DOCS $85.21
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- DOCS 18.12
- PEN 67.31
- Support Level
- DOCS $65.22
- PEN $274.20
- Resistance Level
- DOCS $67.10
- PEN $283.84
- Average True Range (ATR)
- DOCS 2.19
- PEN 8.99
- MACD
- DOCS -1.60
- PEN 5.26
- Stochastic Oscillator
- DOCS 3.05
- PEN 95.78
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.